Recombinant Sodalis glossinidius Lipoprotein Signal Peptidase (LspA) is a bacterial enzyme cloned and expressed in heterologous systems, primarily for research into bacterial physiology, symbiosis, and therapeutic target development. LspA (EC 3.4.23.36), also termed Prolipoprotein Signal Peptidase or SPase II, catalyzes the cleavage of signal peptides from pro-lipoproteins, enabling lipoprotein maturation and membrane localization in Gram-negative bacteria like S. glossinidius . This enzyme is critical for bacterial membrane integrity, immune evasion, and pathogen-host interactions, particularly in symbiotic or pathogenic contexts .
LspA belongs to the aspartic acid protease family, with conserved catalytic aspartates critical for signal peptide cleavage . Its role in S. glossinidius aligns with its function in other Gram-negative bacteria, where lipoproteins anchor to membranes and mediate nutrient uptake or virulence .
| Parameter | Specification |
|---|---|
| Expression Host | E. coli (implied by recombinant production methods) |
| Tag Type | Undetermined during production (variable per batch) |
| Storage Buffer | Tris-based buffer with 50% glycerol |
| Storage Conditions | -20°C (long-term), -80°C (extended storage); aliquots at 4°C for ≤1 week |
| Stability Notes | Avoid repeated freeze-thaw cycles |
Recombinant LspA is supplied at 50 µg quantities, with custom scales available upon request . The enzyme’s recombinant form retains functional activity, as inferred from its use in biochemical assays (e.g., lipoprotein processing studies) .
S. glossinidius is a maternally transmitted endosymbiont of tsetse flies, critical for their survival and implicated in trypanosome susceptibility . While LspA itself has not been directly studied in S. glossinidius, its homologs in pathogens like Staphylococcus aureus and Escherichia coli are validated targets for antibiotics (e.g., globomycin) that disrupt lipoprotein biosynthesis, compromising membrane integrity .
| Species | LspA Function | Therapeutic Relevance |
|---|---|---|
| Staphylococcus aureus | Essential for lipoprotein maturation; targeted by globomycin | Antibiotic development against MRSA |
| Escherichia coli | Involved in outer membrane stability; resistance linked to Lpp downregulation | Antimicrobial strategies against uropathogens |
| S. glossinidius | Likely role in symbiont-midgut interaction and immune evasion | Paratransgenic applications in tsetse control |
In S. glossinidius, LspA may facilitate lipoprotein secretion, enabling survival in the tsetse midgut and hemolymph. Genetic studies on S. glossinidius have focused on symbiosis-related genes (e.g., Type III secretion systems), but LspA remains a candidate for future paratransgenic strategies to block trypanosome transmission .
| Step | Protocol |
|---|---|
| Long-Term Storage | Aliquot into single-use vials; store at -20°C or -80°C |
| Short-Term Use | Thaw aliquot at 4°C; discard after 1 week |
| Freezing/Thawing | Avoid repeated cycles to prevent aggregation or activity loss |
The recombinant protein is stabilized in glycerol to prevent denaturation but should not be exposed to temperatures >4°C during working cycles .
KEGG: sgl:SG0415
STRING: 343509.SG0415
Sodalis glossinidius is a maternally inherited, Gram-negative bacterial endosymbiont of tsetse flies (Glossina spp.; Diptera: Glossinidae). It maintains a stable, chronic association with its insect host and undergoes predominantly maternal transmission . The significance of S. glossinidius in research stems from its unique genomic features and evolutionary state. The genome has undergone extensive degeneration as a result of its ecological transition from free-living existence to permanent host association, with approximately 40-50% of its genome consisting of pseudogenes . This makes S. glossinidius an excellent model system for studying the early stages of symbiosis evolution, as it represents an intermediate stage between free-living bacteria and obligate endosymbionts with highly reduced genomes .
Lipoprotein signal peptidase (LspA) is an aspartyl protease that cleaves the transmembrane helix signal peptide of lipoproteins as part of the lipoprotein-processing pathway . This enzyme plays a critical role in bacterial membrane physiology by processing lipoproteins for proper localization and function. The significance of LspA extends beyond basic bacterial physiology to biomedical applications, as members of the lipoprotein-processing pathway are excellent targets for antibiotic development because they are:
Essential in Gram-negative bacteria
Important for virulence in Gram-positive bacteria
The enzyme exhibits remarkable conformational dynamics, fluctuating on the nanosecond timescale between open and closed conformations, which allows it to accommodate and process a variety of substrates .
Researchers are interested in recombinant S. glossinidius LspA for several compelling scientific reasons:
Antibiotic Development: As LspA is essential in Gram-negative bacteria and important for virulence in Gram-positive bacteria, studying the structure and function of S. glossinidius LspA can provide insights for developing novel antibiotics that target this enzyme .
Evolutionary Biology: Comparing LspA from S. glossinidius (an organism undergoing genome reduction) with LspA from free-living bacteria can illuminate how essential proteins evolve under symbiotic conditions .
Structural Biology: The conformational dynamics of LspA make it an interesting target for understanding membrane protein flexibility and function, with implications for substrate recognition and catalysis .
Host-Symbiont Interactions: Studying the role of LspA in processing S. glossinidius lipoproteins may provide insights into how this organism interacts with its tsetse fly host at the molecular level .
Bacteriophage P1 Transduction: P1 can infect, lysogenize, and promote transduction in S. glossinidius. This technique allows efficient delivery of replication-competent and suicide vectors for genetic manipulation . The process involves:
Packaging plasmid DNA containing the LspA gene into P1 virions in an E. coli P1CM clr-100(ts) lysogen
Delivering these phagemids to S. glossinidius cells
Selecting transductants using appropriate antibiotics
Conjugation: DNA transfer via bacterial conjugation has been established for S. glossinidius . This method can be used for:
Chromosome Tagging: Specific tools have been developed for tagging the S. glossinidius chromosome with fluorescent genes at the Tn7 attachment site, which can be adapted for expression of recombinant proteins .
The optimal growth conditions for S. glossinidius culture are critical for successful recombinant protein expression:
Culture Medium: Brain-heart infusion (BHI) broth supplemented with 10 mM MgCl₂ or brain-heart infusion agar (1.2% w/v) supplemented with 10% defibrinated horse blood and 10 mM MgCl₂ (BHIB) .
Temperature: 27°C
Aeration: Growth in liquid medium should be carried out with aeration (250 rpm)
Atmosphere: Microaerophilic conditions are required for growth on BHIB, achieved either using BD GasPak EZ Campy Gas Generating sachets or a gas mixture (5% oxygen, 95% CO₂)
Antibiotic Selection: When using antibiotic resistance markers, the following concentrations are recommended for S. glossinidius :
Chloramphenicol: 10 μg/mL
Kanamycin: 25 μg/mL
Spectinomycin: 30 μg/mL
Gentamycin: 9 μg/mL
| Culture Parameter | Optimal Condition |
|---|---|
| Medium | BHI broth with 10 mM MgCl₂ |
| Solid Medium | BHIB with 10% horse blood |
| Temperature | 27°C |
| Aeration | 250 rpm |
| Atmosphere | Microaerophilic (5% O₂, 95% CO₂) |
| Growth Time | Longer than E. coli (S. glossinidius grows slowly) |
Verification of proper expression and folding of recombinant S. glossinidius LspA requires a multi-faceted approach:
Expression Confirmation:
Functional Assays:
Enzymatic activity assays measuring the cleavage of signal peptides from lipoproteins
Complementation of LspA-deficient strains to restore lipoprotein processing
Structural Analysis:
Membrane Localization:
The conformational dynamics of LspA are central to its function and critical for understanding its potential as an antibiotic target:
Key Conformational States:
LspA exhibits at least three distinct conformational states with different functional roles :
Closed Conformation: In the apo (unbound) state, LspA predominantly adopts its most closed conformation, where the periplasmic helix (PH) and β-cradle are approximately 6.2 Å apart. This conformation completely occludes the charged and polar active site residues from the lipid bilayer .
Intermediate Conformation: This conformation is stabilized when the antibiotic globomycin is bound and may represent the clamped substrate-bound state .
Open Conformation: This conformation creates a trigonal cavity where the lipoprotein, signal peptide, and diacylglyceryl moiety of the lipoprotein substrate can bind. It is the only conformation that would sterically allow the prolipoprotein to enter and bind in the correct orientation for signal peptide cleavage .
Implications for Antibiotic Development:
The plasticity of LspA and its binding sites presents both challenges and opportunities for drug development:
Understanding the equilibrium between these conformational states is essential for designing inhibitors that can effectively target LspA .
The antibiotic globomycin stabilizes an intermediate conformation that inhibits signal peptide cleavage and substrate binding .
A hybrid experimental design using molecular dynamics (MD) and electron paramagnetic resonance (EPR) has facilitated identification of protein conformations not observed in crystal structures, which will aid future development of therapeutics .
Researchers working with recombinant S. glossinidius LspA face several significant challenges:
Membrane Protein Expression:
LspA is a membrane protein, which typically presents difficulties in expression and purification
The hydrophobic nature of membrane proteins often leads to aggregation or misfolding
Expression levels may be low due to toxicity or cellular stress
S. glossinidius Specific Challenges:
S. glossinidius has undergone genome degeneration, potentially affecting protein folding machinery
The bacterium grows slowly under laboratory conditions, making large-scale protein production time-consuming
S. glossinidius is refractory to harsh artificial DNA transformation procedures due to the loss of stress response pathways
Protein Purification Issues:
Activity Preservation:
The integration of MD simulations and EPR represents a powerful approach for studying S. glossinidius LspA conformational dynamics:
EPR Techniques:
Continuous Wave (CW) EPR can detect motion on the nanosecond timescale, appropriate for studying LspA dynamics
Double Electron-Electron Resonance (DEER) EPR measures distance distributions between labeled sites, revealing different conformational populations
Site-directed spin labeling allows specific regions (like the periplasmic helix) to be monitored
MD Simulation Approaches:
EPR-Guided Simulations:
EPR distance measurements can be used as constraints for MD simulations
CW EPR data on timescales of motion can validate simulation timeframes
Simulation Validation by EPR:
Conformations predicted by MD can be tested experimentally using strategic spin labeling sites
Predicted distances between residues can be measured by DEER EPR
Iterative Refinement:
Results from each method inform refinement of the other in an iterative process
Combined data allows construction of a complete conformational landscape
This hybrid approach has already proven valuable in LspA research, revealing conformations not observed in crystal structures alone .
A robust experimental design for studying recombinant S. glossinidius LspA should include the following controls:
Catalytically inactive LspA mutant (e.g., mutation of active site aspartate residues)
Heat-denatured LspA to confirm the requirement for proper protein folding
Reactions without LspA to establish baseline activity
Reactions without substrate to detect any background signal
Well-characterized LspA from model organisms (e.g., E. coli LspA)
Known LspA inhibitor (globomycin) to demonstrate specific inhibition
Pre-validated substrate to ensure the assay is functioning properly
Western blot analysis to confirm expression levels
Mass spectrometry to verify protein identity
Comparison of wild-type and mutant LspA conformational dynamics
Parallel analysis of LspA from S. glossinidius and its free-living relative S. praecaptivus
Designing experiments to investigate LspA-inhibitor interactions requires a comprehensive approach:
Isothermal Titration Calorimetry (ITC) to measure binding thermodynamics
Surface Plasmon Resonance (SPR) to determine binding kinetics
Fluorescence-based binding assays if suitable fluorescent probes can be introduced
EPR spectroscopy to determine how inhibitors affect conformational distributions
X-ray crystallography to obtain structures of LspA-inhibitor complexes
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify regions involved in inhibitor binding
Enzyme inhibition assays with various concentrations of inhibitors to determine IC₅₀ values
Determination of inhibition mechanisms (competitive, non-competitive, uncompetitive)
Time-dependent inhibition studies to identify slow-binding or irreversible inhibitors
Molecular docking to predict binding modes of inhibitors
MD simulations to investigate how inhibitors affect LspA dynamics
Virtual screening to identify novel inhibitor candidates
Growth inhibition assays with S. glossinidius and related bacteria
Measurement of cellular lipoprotein processing in the presence of inhibitors
Assessment of membrane integrity and functionality with inhibitor treatment
Understanding how LspA conformational changes affect substrate specificity requires specialized techniques:
EPR spectroscopy to monitor conformational distributions in different conditions
Single-molecule FRET to observe conformational dynamics in real-time
HDX-MS to identify regions with altered solvent accessibility in different states
Synthetic peptide libraries representing different lipoprotein signal sequences
Mass spectrometry-based identification of cleaved substrates from cell lysates
Fluorogenic substrates with varying sequences to measure cleavage kinetics
Site-directed mutagenesis to alter residues involved in conformational changes
Chimeric proteins combining domains from LspA enzymes with different specificities
Correlation of EPR-determined conformational states with substrate preferences
Molecular dynamics simulations of LspA with different substrates
Free energy calculations to compare binding energies of different substrates
Machine learning to identify sequence patterns preferentially cleaved in different conformational states
Expression of mutant LspA variants in S. glossinidius or S. praecaptivus
Proteomic analysis to identify processed lipoproteins in vivo
Phenotypic assessment of cells expressing conformationally restricted LspA variants
Recombinant S. glossinidius LspA research offers significant potential for antibiotic development:
LspA as an Antibiotic Target:
LspA is considered an excellent target for antibiotic development because:
It is essential in Gram-negative bacteria
It is important for virulence in Gram-positive bacteria
Structural Insights:
Understanding the conformational dynamics of LspA provides a foundation for structure-based drug design
The identification of multiple binding modes for globomycin informs the design of more effective inhibitors
The discovery of three distinct conformational states (closed, intermediate, and open) offers multiple potential targeting strategies
Mechanism-Based Inhibitor Design:
Novel Screening Approaches:
Development of assays based on conformational changes rather than just enzymatic activity
High-throughput screens for compounds that lock LspA in inactive conformations
Resistance Prevention Strategies:
Recombinant S. glossinidius LspA research has significant implications for paratransgenic disease control strategies:
Paratransgenesis Concept:
Paratransgenesis involves genetically modifying symbiotic bacteria within disease vectors to express molecules that interfere with pathogen development or transmission. Since S. glossinidius naturally inhabits tsetse flies, it presents an attractive platform for paratransgenic approaches to control tsetse-transmitted diseases like African trypanosomiasis .
Modified LspA as a Processing Tool:
Engineered LspA could be used to process and display anti-trypanosome effector molecules on the S. glossinidius surface
LspA's role in lipoprotein processing could be exploited to anchor therapeutic proteins to the bacterial membrane
Vector Development:
Stability and Expression:
Monitoring Tools:
Techniques developed for studying recombinant LspA expression could be adapted to monitor the stability and spread of paratransgenic modifications in field populations